This episode delves into the complexities of botulinum neurotoxin (BoNT) dosages in aesthetic medicine, focusing on the risks associated with higher doses and the potential for developing resistance. The discussion covers the difference in dosages between aesthetic and therapeutic uses, the relevance of immunogenicity, and strategies to mitigate risks, such as opting for purer forms of the toxin like incobotulinum toxin A (incoBoNT-A). Emphasis is placed on the importance of minimal effective dosing and thorough record-keeping to maintain the longevity and efficacy of BoNT treatments, helping healthcare providers and patients stay informed and achieve optimal outcomes.
Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for healthcare:
🎥 Watch on YouTube for in-depth AI tutorials: YouTube.com/@DrTeriFisher
📲 Follow on Instagram for automation tips: @DrTeriFisher
💡 Discover AI tools for your practice: DrTeriFisher.com
🎙 Listen to the long-form podcast: Anti-Aging Insights
👉 Subscribe to AI Automation Minute for your daily dose of AI-powered efficiency, and share with colleagues who want to work smarter, not harder!
#AIAutomationMinute #DrTeriFisher #HealthcareAI
